Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes. [electronic resource]
Producer: 20120509Description: 2310-5 p. digitalISSN:- 1930-739X
- Adiponectin -- blood
- Adipose Tissue -- drug effects
- Alanine Transaminase -- blood
- Aspartate Aminotransferases -- blood
- Biomarkers -- blood
- Blood Glucose -- metabolism
- Body Mass Index
- Body Weight -- drug effects
- Diabetes Mellitus, Type 2 -- diet therapy
- Drug Therapy, Combination
- Exenatide
- Fasting
- Fatty Acids, Nonesterified -- blood
- Glucagon-Like Peptide-1 Receptor
- Glycated Hemoglobin -- metabolism
- Humans
- Hypoglycemic Agents -- pharmacology
- Liver -- drug effects
- Magnetic Resonance Spectroscopy
- Metformin -- therapeutic use
- Middle Aged
- Obesity -- complications
- PPAR gamma -- agonists
- Peptides -- pharmacology
- Pioglitazone
- Receptors, Glucagon -- agonists
- Thiazolidinediones -- pharmacology
- Triglycerides -- blood
- Venoms -- pharmacology
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.